ChemoCentryx, Inc.
CCXI
CCXI was delisted on the 19th of October, 2022.
72 hedge funds and large institutions have $137M invested in ChemoCentryx, Inc. in 2016 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 21 reducing their positions, and 11 closing their positions.
392% more call options, than puts
Call options by funds: $118K | Put options by funds: $24K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
34% more capital invested
Capital invested by funds: $103M → $137M (+$34.5M)
19% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 21
6% less funds holding
Funds holding: 77 → 72 (-5)
36% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AG
Artal Group
Luxembourg
|
+$1.42M |
| 2 |
Acadian Asset Management
Boston,
Massachusetts
|
+$792K |
| 3 |
Renaissance Technologies
New York
|
+$606K |
| 4 |
SIM
Spark Investment Management
New York
|
+$575K |
| 5 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$508K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$988K |
| 2 |
Bank of America
Charlotte,
North Carolina
|
-$567K |
| 3 |
BI
BVF Inc
San Francisco,
California
|
-$558K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
-$554K |
| 5 |
NFA
Nationwide Fund Advisors
Columbus,
Ohio
|
-$382K |
CCXI Hedge Fund Activity: Q3 2016 in Review
72 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2016, worth a combined $137M — up 34% from $103M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CCXI and 7 opened new positions — a net loss of 4 holders — while 21 trimmed existing stakes and 25 added.
The largest buyer was Artal Group, adding an estimated $1.42M. The largest seller was Oxford Asset Management, cutting an estimated $988K.
- 72 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2016, down from 77 in Q2 2016.
- Funds reported $137M of ChemoCentryx, Inc. stock for Q3 2016, up 34% quarter-over-quarter.
- 7 funds opened new ChemoCentryx, Inc. positions in Q3 2016 and 11 closed out, a net change of -4 holders.
- The largest ChemoCentryx, Inc. buyer in Q3 2016 was Artal Group, an estimated $1.42M added.
- The largest ChemoCentryx, Inc. seller in Q3 2016 was Oxford Asset Management, an estimated $988K sold.
Based on aggregated 13F filings for Q3 2016.